Plexus CEO Kelsey sells $1m+ in PLXS stock
Plexus Corp (NASDAQ:PLXS) CEO Todd P. Kelsey sold 5,231 shares of company stock for over $1 million, executed under a pre-arranged Rule 10b5-1 trading plan. Prior to this, Kelsey acquired 18,726 shares through exercised performance stock units and disposed of 8,802 shares to cover tax obligations. These transactions come as Plexus's stock shows strong performance, and the company recently reported solid first-quarter fiscal year 2026 financial results, with EPS and revenue meeting or exceeding expectations.
Plexus exec VP Mihm sells $2.36 million in PLXS stock
Oliver K. Mihm, Executive Vice President and COO of PLEXUS CORP (NASDAQ:PLXS), sold 11,767 shares of company stock for approximately $2.36 million on February 17 and 18, 2026. These sales occurred after a significant stock price increase and coincided with the company reporting strong Q1 fiscal year 2026 results, exceeding EPS expectations. During the same period, Mihm also acquired shares and Performance Stock Units through vesting, while also disposing of shares to cover tax obligations.
Plexus Shareholders Reelect Board and Approve Executive Pay
Plexus shareholders reelected all ten director nominees to one-year terms and approved executive compensation at their 2026 Annual Meeting. They also ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal 2026, indicating strong support for current governance and financial oversight. An analyst rating on Plexus (PLXS) stock is a Buy with a $227.00 price target, and TipRanks’ AI Analyst, Spark, rates PLXS as Outperform due to strong technical momentum and solid fundamentals.
Public Sector Pension Investment Board Boosts Stock Position in Plexus Corp. $PLXS
The Public Sector Pension Investment Board increased its stake in Plexus Corp. (NASDAQ:PLXS) by 13.9% in the third quarter, now owning 105,224 shares valued at over $15 million. This move is part of a trend of high institutional ownership in Plexus, which stands at 94.45%, while insiders have been selling shares. The company recently beat earnings expectations and provided strong Q2 2026 guidance, leading to raised price targets from analysts, though the average target remains below current trading levels.
AlphaQuest LLC Sells 19,843 Shares of Plexus Corp. $PLXS
AlphaQuest LLC significantly reduced its stake in Plexus Corp. ($PLXS) by 97.2% in Q3, selling 19,843 shares. This institutional selling coincides with notable insider selling by Plexus's CEO and CFO, who disposed of shares worth over $2.6 million. Despite the institutional and insider selling, Plexus slightly beat Q1 EPS estimates and provided positive Q2 2026 EPS guidance, maintaining a "Moderate Buy" analyst consensus.
Have Plexus Insiders Been Selling Stock?
Plexus Corp. Non-Executive Chairman Dean Foate recently sold US$2.1 million worth of stock, reducing his holding by 8.0%. While this was the largest insider sale in the past year, it occurred at approximately the current share price, which is considered less concerning than sales at lower prices. Despite the selling activity, insiders collectively own 1.6% of the company, valued at about US$90 million.
Have Plexus Insiders Been Selling Stock?
Plexus Corp. (NASDAQ:PLXS) recently saw its Non-Executive Chairman, Dean Foate, sell shares worth US$2.1 million. While this was a significant sale, reducing his holding by 8.0%, he remains heavily invested in the stock, and the sale occurred near the current share price. There have been no insider purchases of Plexus stock in the last year, suggesting caution for potential investors despite the company's growing earnings.
Plexus Corp stock hits all-time high at 208.99 USD
Plexus Corp (PLXS) stock has reached an all-time high of $208.99 USD, reflecting a 46.12% increase over the past year and a 59.08% surge in the last six months. Despite a market capitalization of $5.58 billion suggesting it might be slightly overvalued by InvestingPro Fair Value, the company exhibits strong financial health with a Piotroski Score of 9 and significant growth potential, evidenced by a favorable PEG ratio of 0.63. Recent Q1 fiscal year 2026 results further support its strong performance with EPS of $1.78 and revenue of $1.07 billion.
Plexus Corp. (PLXS) Soars to 52-Week High, Time to Cash Out?
Plexus Corp. (PLXS) recently hit a new 52-week high of $211.84, showing strong performance with a 29.9% gain over the past month and 41.7% year-to-date. The stock has a positive earnings surprise history and a Zacks Rank of #2 (Buy), suggesting potential for continued growth. However, its valuation metrics, such as a P/E of 27.4X and P/CF of 22.1X, are at a premium compared to its industry peers.
Plexus Corp. (NASDAQ:PLXS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Plexus Corp. (NASDAQ:PLXS) has received a "Moderate Buy" consensus recommendation from five analysts, with an average 12-month price target of $189.20. The company recently reported strong Q1 2026 earnings, beating EPS estimates and meeting revenue expectations, with Q2 2026 EPS guidance set between $1.80 and $1.95. Despite some insider selling, institutional ownership remains high at 94.45%, reflecting continued market confidence.
Plexus Corp stock hits all-time high at 208.99 USD By Investing.com
Plexus Corp (PLXS) stock reached an all-time high of $208.99, reflecting strong investor confidence and significant growth. The company, an electronic manufacturing services provider, has seen its stock price increase by 46.12% over the past year and boasts an exceptional financial health with a Piotroski Score of 9. Despite appearing slightly overvalued, its favorable PEG ratio of 0.63 indicates strong growth potential, supported by robust Q1 fiscal year 2026 results.
Plexus Corp stock hits all-time high at 208.99 USD By Investing.com
Plexus Corp stock has reached an all-time high of $208.99, demonstrating strong investor confidence with a 46.12% increase over the past year and a 59.08% surge in six months. The company, an electronic manufacturing services provider with a market cap of $5.58 billion, exhibits exceptional financial health, a perfect Piotroski Score of 9, and strong growth potential despite appearing slightly overvalued by InvestingPro Fair Value assessments. Plexus Corp also reported strong Q1 2026 financial results, exceeding EPS expectations and meeting revenue forecasts.
Plexus Corp stock hits all-time high at 208.99 USD
Plexus Corp stock has reached an all-time high of $208.99 USD, reflecting strong investor confidence and solid financial health, as evidenced by a Piotroski Score of 9. Despite appearing slightly overvalued, the company shows strong growth potential due to its favorable PEG ratio of 0.63 and robust Altman Z-Score. This milestone follows strong Q1 fiscal year 2026 financial results with earnings surpassing expectations.
Plexus Corp stock hits all-time high at 208.99 USD
Plexus Corp's stock reached an all-time high of $208.99, demonstrating strong investor confidence with a 46.12% increase over the past year. Despite appearing slightly overvalued by InvestingPro, the company shows exceptional financial health with a Piotroski Score of 9 and solid growth potential. Plexus Corp also reported strong Q1 fiscal year 2026 results, surpassing EPS expectations and meeting revenue forecasts.
Why Plexus (PLXS) Might be Well Poised for a Surge
Plexus (PLXS) is showing strong potential for a stock surge due to significant upward revisions in its earnings estimates by analysts. The company currently holds a Zacks Rank #1 (Strong Buy), indicating a favorable outlook based on these improved earnings prospects. Investors are encouraged to consider Plexus for their portfolios, given its positive estimate revisions and recent stock performance.
Are You Looking for a Top Momentum Pick? Why Plexus (PLXS) is a Great Choice
Plexus (PLXS) is identified as a top momentum pick with a Zacks Rank #1 (Strong Buy) and a Momentum Style Score of A. The article highlights its recent price performance, outperforming both its industry and the S&P 500 over various periods, and positive earnings estimate revisions, suggesting continued upward trajectory for the stock. Investors looking for short-term growth are advised to consider PLXS.
What Plexus (PLXS)'s Strong Q1 Beat, Guidance and Buybacks Mean For Shareholders
Plexus Corp. (PLXS) reported strong Q1 2026 results, surpassing analyst expectations with US$1,069.85 million in sales and US$41.18 million in net income. The company also provided upbeat Q2 revenue guidance of US$1.11 billion to US$1.15 billion and completed a US$37.37 million share repurchase program. While the strong performance reinforces Plexus's execution-driven investment narrative, investors should be aware of its premium valuation and recent insider selling.
Insider Sell: Ninivaggi Angelo Michael Jr Sells Shares of Plexus Corp (PLXS)
Ninivaggi Angelo Michael Jr, Executive Vice President at Plexus Corp, recently sold 4,303 shares of the company, bringing his total ownership to 20,099 shares. This sale is part of a trend over the past year where insiders have sold 37 times with no purchases. Plexus Corp (PLXS) is currently trading at $203.06, which is significantly overvalued according to its GuruFocus Value of $119.01, with a price-to-GF-Value ratio of 1.71.
Plexus (NASDAQ:PLXS) CAO Angelo Michael Ninivaggi Jr Sells 4,303 Shares
Plexus CAO Angelo Michael Ninivaggi Jr. sold 4,303 shares of Plexus stock on February 5th at an average price of $203.06, totaling approximately $873,767. This transaction reduced his ownership by 17.63% to 20,099 shares. The sale occurred shortly after Plexus reported Q1 EPS of $1.78, beating estimates, and a revenue of $1.07 billion, leading to a stock increase of about 2.6%.
Insider Selling: Plexus (NASDAQ:PLXS) CFO Sells $732,070.83 in Stock
Plexus Corp. (NASDAQ:PLXS) CFO Patrick John Jermain sold 3,587 shares of company stock worth $732,070.83 on February 4th, reducing his stake by 17.52%. Including earlier sales, his total insider dispositions recently amounted to about $2.01 million. Despite a narrow EPS beat and revenue growth, the stock is near its 52-week high, and analysts currently have a "Hold" rating with a consensus price target below the current share price.
Why Plexus (PLXS) is a Top Momentum Stock for the Long-Term
Plexus (PLXS) has been identified as a top momentum stock for long-term investors, backed by strong Zacks Style Scores. The article highlights how the Zacks Rank and Style Scores (Value, Growth, Momentum, VGM) help investors identify stocks with high potential to outperform the market. PLXS, with a Zacks Rank #3 (Hold), a Momentum Score of A, and a VGM Score of A, shows strong promise due to recent positive earnings estimate revisions and significant stock price appreciation.
What Plexus (PLXS)'s Strong Q1 Beat, Guidance and Buybacks Mean For Shareholders
Plexus Corp. reported strong Q1 2026 results, exceeding analyst expectations with US$1,069.85 million in sales and US$41.18 million in net income. The company issued optimistic Q2 revenue guidance of US$1.11 billion to US$1.15 billion and diluted EPS of US$1.53 to US$1.68, alongside completing a US$37.37 million share repurchase program. While the strong performance and guidance support an upbeat investment narrative, the premium valuation and recent insider selling introduce some risk for shareholders.
Foate, Plexus Corp chairman, sells $1m in PLXS stock By Investing.com
Dean A. Foate, Chairman of Plexus Corp (NASDAQ:PLXS), sold 5,000 shares of company common stock for over $1 million on February 2, 2026. This transaction reduced his indirect holdings to 15,000 shares. Separately, on February 3, he acquired 1,370 shares through the vesting of Restricted Stock Units, following strong financial results for Q1 fiscal year 2026 for Plexus Corp.
Foate, Plexus Corp chairman, sells $1m in PLXS stock By Investing.com
Dean A. Foate, Chairman of Plexus Corp (NASDAQ:PLXS), sold 5,000 shares of company stock worth over $1 million on February 2, 2026. This transaction reduced his indirect holdings to 15,000 shares. Concurrently, on February 3, he acquired 1,370 shares through the vesting of Restricted Stock Units.
Dean Foate Sells 5,000 Shares of Plexus (NASDAQ:PLXS) Stock
Plexus Chairman Dean Foate sold 5,000 shares of the company's stock for over $1 million, reducing his stake by 25%. This insider sale, along with similar sales by the CEO and CFO, raises investor concerns despite the company's recent share price strength and an earnings beat. Analysts maintain a "Hold" rating on PLXS, with a consensus target price of $189.20.
The Top 5 Analyst Questions From Plexus's Q4 Earnings Call
Plexus exceeded Q4 non-GAAP EPS expectations, with revenue meeting analyst estimates, driven by strong growth in Healthcare/Life Sciences and Aerospace/Defense. Management attributed success to program ramps, improved end-market demand, and operational efficiencies. Analysts questioned growth drivers, Aerospace & Defense demand, supply chain management, semicap growth, and margin headwinds, all of which were addressed by the company executives.
PLEXUS CORP SEC 10-Q Report
Plexus Corp (PLXS) has released its Form 10-Q report for the third quarter, showcasing robust financial performance with a 9.6% increase in net sales to $1,069.9 million, driven by increased customer demand and new product production ramps. The company reported a net income of $41.2 million, up 10.5%, and diluted earnings per share of $1.51. Key growth areas included the Aerospace/Defense and Healthcare/Life Sciences sectors, with an optimistic outlook for fiscal 2026 capital expenditures and tax rates.
Michael Running Sells 926 Shares of Plexus (NASDAQ:PLXS) Stock
Plexus (NASDAQ:PLXS) insider Michael Running sold 926 shares of the company's stock on February 2nd, 2026, for a total value of approximately $189,755.92. This transaction reduced his stake by 41.69%, leaving him with 1,295 shares. The sale followed Plexus's recent earnings report, which beat analyst estimates, and the company provided strong Q2 2026 guidance.
Plexus (PLXS) Price Target Increased by 26.29% to 204.82
The average one-year price target for Plexus (NasdaqGS:PLXS) has increased by 26.29% to $204.82 per share from a prior estimate of $162.18. This target, based on analyst projections ranging from $174.73 to $231.00, represents a slight decrease of 0.07% from the latest closing price. Institutional ownership in Plexus shows a decrease in the number of funds holding positions, but some major holders like Fiduciary Management and American Century Companies have significantly increased their stakes.
Thrivent Financial for Lutherans Purchases 19,248 Shares of Plexus Corp. $PLXS
Thrivent Financial for Lutherans increased its stake in Plexus Corp. by 6.9%, acquiring an additional 19,248 shares, bringing their total ownership to 298,117 shares valued at approximately $43.13 million. The technology company's stock has an average "Hold" rating from analysts with a consensus price target of $189.20. Despite recent insider selling, Plexus reported strong quarterly earnings, beating estimates by $0.01 EPS and forecasting Q2 2026 guidance between $1.80 and $1.95 EPS.
Plexus' Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
Plexus Corp. (PLXS) reported first-quarter fiscal 2026 adjusted EPS of $1.78, beating the Zacks Consensus Estimate of $1.77, with revenues of $1.07 billion. While revenues increased 9.6% year-over-year, they slightly missed estimates. The company saw strong growth in Americas, EMEA, and Asia-Pacific, along with program wins totaling $283 million in annualized revenues and provided a positive outlook for Q2 fiscal 2026.
(PLXS) Volatility Zones as Tactical Triggers
This article analyzes Plexus Corp. (NASDAQ: PLXS) using AI models to identify volatility zones as tactical triggers. It indicates strong sentiment supporting an overweight bias and ongoing breakout, with potential for higher levels but also elevated downside risk. The analysis provides different trading strategies (position, momentum breakout, risk hedging) and multi-timeframe signal analysis with support and resistance levels.
Plexus price target raised to $220 from $195 at Benchmark
Benchmark has increased its price target for Plexus (PLXS) to $220 from $195, maintaining a Buy rating. This adjustment follows stronger-than-expected results and an "upbeat tone" regarding future demand momentum. The firm expressed surprise at the strength of Plexus's Q2 guidance.
Plexus Corp (PLXS) Shares Up 5.19% on Jan 30
Plexus Corp (PLXS) shares rose 5.19% on January 30, closing at $207.94, just shy of its 52-week high. Wall Street analysts have an average target price of $191.20, suggesting a potential downside, while GuruFocus estimates a fair value of $127.53, indicating a larger downside. The consensus brokerage recommendation for PLXS is "Hold."
Stifel raises Plexus stock price target to $200 on strong outlook
Stifel has increased its price target for Plexus (NASDAQ:PLXS) to $200, maintaining a Hold rating despite the stock already trading above this new target at $208.22. The company reported strong fiscal first-quarter 2026 results, meeting revenue guidance and exceeding EPS expectations, driven by growth in Healthcare/Life Sciences and recovery in semiconductor capital equipment demand. Plexus also provided optimistic fiscal year 2026 revenue guidance, expecting to meet or exceed the high end of its 9% to 12% growth target, supported by record aerospace and defense program wins.
Plexus Corp. (NASDAQ:PLXS) Q1 2026 Earnings Call Transcript
Plexus Corp. (NASDAQ:PLXS) reported strong Q1 2026 results, with revenue meeting guidance and non-GAAP EPS at the high end, driven by growth in Healthcare/Life Sciences and Aerospace and Defense sectors. The company secured 22 new manufacturing programs worth $283 million annually and anticipates meeting or exceeding its 9% to 12% revenue growth goal for fiscal 2026, supported by robust demand and strategic investments in efficiency and technology. Plexus expects continued momentum in Q2 2026 with further revenue and operating margin growth while managing working capital and investing in automation.
Plexus (PLXS) TTM Earnings Surge Of 45.7% Tests Bullish Growth Narratives
Plexus (PLXS) reported strong Q1 2026 results with revenue of US$1.1 billion and basic EPS of US$1.54, leading to a 45.7% surge in trailing twelve-month earnings. While recent profitability is high, forecast growth is lower, raising questions about the sustainability of this surge. The stock's P/E ratio is 29.9x, above the industry average but significantly above its DCF fair value, prompting caution among investors.
PLXS Q4 Deep Dive: Program Ramps and Market Share Gains Drive Guidance Upgrade
Plexus (NASDAQ:PLXS) exceeded revenue and non-GAAP EPS expectations in Q4 CY2025, driven by strong program ramps in Healthcare/Life Sciences and Aerospace and Defense, and improved demand in semiconductor and energy markets. The company upgraded its Q1 CY2026 revenue and EPS guidance, anticipating continued market share gains, new business wins, and demand momentum across key verticals. Management highlighted ongoing investments in operational efficiency and automation to support future growth and margin expansion.
Plexus Corp stock hits all-time high at 189.43 USD By Investing.com
Plexus Corp (PLXS) stock reached an all-time high of $189.43, reflecting a 28.17% increase over the past year and a 40.72% gain in six months. This surge is supported by the company's strong financial health and a perfect Piotroski Score of 9. The new high comes after the company reported better-than-expected first-quarter 2026 earnings, with an EPS of $1.78 and revenue of $1.07 billion.
Plexus Sees Optimistic Financial Projections Amid Strong Performance
Plexus Corp. (NASDAQ: PLXS) has seen a significant stock increase of 9.26% due to major product launches and strategic market expansions. Analysts have boosted the company's target stock value to $195, anticipating strong fiscal Q1 and Q2 performance with expected earnings per share between $1.80 and $1.95, and revenue projections of $1.11B to $1.15B. The growth is attributed to new programs, market share gains, and robust performance in healthcare and defense sectors, fueling investor confidence.
Plexus' Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
Plexus Corp. (PLXS) reported first-quarter fiscal 2026 adjusted earnings of $1.78 per share, surpassing the Zacks Consensus Estimate of $1.77. Revenues increased by 9.6% year over year to $1.07 billion, though they slightly missed estimates. The company anticipates continued revenue growth for fiscal 2026, driven by new manufacturing program wins and strengthening market demand in sectors like Aerospace/Defense and Healthcare/Life Sciences.
Plexus signals potential to exceed 12% revenue growth for fiscal 2026 amid robust market share gains
Plexus is optimistic about exceeding its 12% revenue growth target for fiscal year 2026. The company anticipates strong performance driven by significant market share gains and a robust pipeline valued at over $1.5 billion, indicating continued expansion and financial success.
Plexus Corp stock hits all-time high at 189.43 USD
Plexus Corp (PLXS) stock reached an all-time high of $189.43, reflecting a 28.17% increase over the past year and a 40.72% gain in six months. This positive performance is supported by a perfect Piotroski Score of 9 and a "GOOD" financial health rating, despite trading slightly above its Fair Value. The company recently reported better-than-expected Q1 2026 earnings per share and met revenue projections, reinforcing investor confidence in its growth trajectory.
Plexus' Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
Plexus Corp. (PLXS) reported first-quarter fiscal 2026 adjusted earnings per share of $1.78, beating the Zacks Consensus Estimate, with revenues of $1.07 billion increasing nearly 9.6% year over year. The company saw significant revenue growth in the Americas, EMEA, and Healthcare/Life Sciences segments. Plexus also announced 22 new manufacturing program wins expected to generate $283 million in annualized revenues and provided a positive outlook for Q2 fiscal 2026.
Plexus' Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
Plexus Corp. (PLXS) reported strong first-quarter fiscal 2026 results, with adjusted EPS of $1.78 surpassing the Zacks Consensus Estimate and revenues increasing 9.6% year over year to $1.07 billion. The company saw significant revenue growth in the Americas, EMEA, and Healthcare/Life Sciences segments, and announced 22 new manufacturing program wins expected to generate $283 million in annualized revenues. Plexus provided positive guidance for the second quarter of fiscal 2026, anticipating revenues between $1.11 billion and $1.15 billion and non-GAAP EPS between $1.80 and $1.95.
Plexus: Fiscal Q1 Earnings Snapshot
Plexus Corp. (PLXS) reported strong fiscal first-quarter results, with net income reaching $41.2 million and adjusted earnings of $1.78 per share, surpassing Wall Street expectations. The company also posted revenues of $1.07 billion, matching forecasts. Looking ahead, Plexus projects per-share earnings of $1.80 to $1.95 and revenues between $1.11 billion and $1.15 billion for the fiscal second quarter.
Plexus (NASDAQ:PLXS) Reports Q4 CY2025 In Line With Expectations
Plexus (NASDAQ:PLXS) reported Q4 CY2025 revenue of $1.07 billion, in line with analyst estimates and up 9.6% year-on-year. The company's non-GAAP EPS of $1.78 surpassed consensus estimates by 2.7%. Plexus provided strong guidance for Q1 CY2026, with revenue projected at $1.13 billion and adjusted EPS at $1.88, both above analyst expectations.
Plexus: Fiscal Q1 Earnings Snapshot
Plexus Corp. (PLXS) reported strong fiscal first-quarter earnings, with net income of $41.2 million and adjusted earnings of $1.78 per share, surpassing Wall Street expectations. The company achieved revenue of $1.07 billion, matching forecasts, and provided optimistic guidance for the fiscal second quarter with expected earnings between $1.80 and $1.95 per share and revenue ranging from $1.11 billion to $1.15 billion.
Plexus Corp (PLXS) Tops Q1 EPS by 3c, provides guidance
Plexus Corp (PLXS) reported Q1 EPS of $1.78, beating the analyst estimate by $0.03, with revenue matching expectations at $1.07 billion. The company also provided strong guidance for Q2 2026, forecasting EPS of $1.80-$1.95 against a consensus of $1.76, and revenue of $1.11-$1.15 billion, exceeding the $1.084 billion consensus.
Plexus Announces Fiscal First Quarter Financial Results
Plexus Corp. (NASDAQ: PLXS) announced strong financial results for its fiscal first quarter ended January 3, 2026, with revenue of $1.070 billion and GAAP diluted EPS of $1.51, and non-GAAP diluted EPS of $1.78. The company also provided optimistic guidance for the fiscal second quarter, projecting revenue between $1.110 billion and $1.150 billion. Plexus attributes this performance to significant customer success, strategic investments, and strong growth in its Healthcare/Life Sciences and Aerospace/Defense market sectors.
